Tmem230a may have a modulatory role in vessel-network formation and growth. Our study supports that the activity of Tmem230a is through restricting Vegfc/Flt4 signaling.
As the Tmem230 sequence is conserved in human, Tmem230 may represent a promising novel target for drug discovery and for disease therapy and regenerative medicine in promoting or restricting angiogenesis. 
Introduction
In embryonic development two distinct processes take place to form the vascular tree.
New vessels form de novo for the assembly of mesoderm-derived endothelial precursors (angioblasts) that differentiate into a primitive vascular labyrinth (vasculogenesis).
Subsequently, vessel sprouting allows the formation of smaller size vessels (angiogenesis) necessary for growth of a vascular tree necessary creating a network that remodels into arteries and veins (Adams and Alitalo, 2007) .
Growth of a vascular tree requires the coordinated control of different functions including proliferation, directional migration and patterning of endothelial cells (ECs). Angiogensis is orchestrated by the regulatory interactions between the vascular endothelial growth factor (Vegf) and Notch signaling pathways that finely control the behavior and positional fate of ECs and determine which cells become tip or stalk behaving cells (Phng and Gerhardt, 2009 ) (Eilken and Adams, 2010) .
The exposure of vessels to pro-angiogenic signals such as Vegf induces the tip cell phenotype only in a fraction of the ECs (Phng and Gerhardt, 2009 ) (Eilken and Adams, 2010) . Tip cell behaviour is strongly controlled by the Notch pathway. Activation of Notch signaling occurs predominantly in stalk cells and takes place by the interaction of Notch with its ligand delta-like 4, Dll4, leading to the down-regulation of both the Vegfa and Vegfc receptors (Vegfr-2 and Vegfr-3/Flt4, respectively) in these cells (Hellstrom, 2007; Lobov, 2007; Tammela et al., 2008) . Therefore, cells with higher levels of Dll4, low Notch activity and strong Vegf receptor transcription are thought to convert into tip cells. (Phng and Gerhardt, 2009 ). We identified two tmem230 paralogous genes in zebrafish, tmem230a and tmem230b, and investigated their expression patterns and determined that tmem230a is expressed in the vascular districts in early zebrafish development. Our data reveal that Tmem230a
regulates the number of endothelial cells in vessels formed through angiogenic processes by cooperating with the Delta/Notch signalling pathway. In this capacity Tmem230a may have a modulatory role in vessel-network formation and growth.
As only a fraction of the ECs acquires angiogenic behavior required for blood vessel branching, the identification of novel regulators of angiogenesis contributes to a better understanding of both the complex multifaceted regulation of angiogenesis in normal and pathological conditions. Signficantly, as the tmem230a sequence is conserved in mammals, TMEM230 may represent a new target for human therapy, in promoting or restricting angiogenesis in acute injury and chronic disease, and since blood vessel formation is also required for promoting tumor growth, invasion and metastasis, TMEM230 may also represent a novel target for human cancer therapy.
Materials and Methods

Zebrafish lines and maintenance.
Zebrafish (Danio rerio) embryos obtained from natural spawning were raised and maintained according to established techniques (Westerfield, 1993 (Kimmel et al., 1995) . Beginning from 24 hpf, embryos were cultured in fish water containing 0.003% PTU (1-phenyl-2-thiourea; Sigma Aldrich, Saint Louis, Mo, USA) to prevent pigmentation and 0.01% methylene blue to prevent fungal growth.
The following lines were used: AB (obtained from the Wilson lab, University College London, London, United Kingdom), tg(fli1:nEGFP) y7 (Roman et al., 2002) , tg(fli1:EGFP) y1 Prediction of transmembrane regions, topology and orientation analysis was performed using TMPRED (http://www.ch.embnet.org/software/TMPRED_form.html) (Hofmann, 1993) and HMMTOP (http://www.enzim.hu/hmmtop/index.php) (Tusnady and Simon, 2001 ). 
Expression pattern analysis.
RT-PCR (Reverse
GCTGAGATCTCTGTCAGTCG 3'. Specific βactin primers were used as internal control to check cDNA quality and possible genomic contamination (Argenton et al., 2004) .
In situ hybridization and imaging.
Whole-mount in situ hybridization (WISH) was performed as described (Thisse et al., 1993; Wu et al., 2011) . For tmem230a and tmem230b probe preparations, templates spanning the last portion of coding sequence and the 3' UTR region for tmem230a or the entire coding sequence for tmem230b were generated by RT-PCR on total RNA extracted from 26 hpf embryos using the following primers: tmem230a new1F:
GCTGAGATCTCTGTCAGTCG 3'. PCR products were cloned into the pGEM®-T Easy vector (Promega). 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   7   7 The cDNA-containing plasmids were linearized and transcribed with T7 and Sp6 RNA polymerase (Roche) for antisense and sense riboprobe synthesis.
Plasmid probes for flk1 (Fouquet et al., 1997) , flt4 (Thompson et al., 1998) , and dll4 (Siekmann and Lawson, 2007) were kindly provided by N.D Lawson, and efnb2a and ephB4 (Lawson et al., 2001) were kindly provided by R. Patient (Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, U.K.).
Images of stained embryos were taken with a Leica MZFLIII epifluorescence stereomicroscope equipped with a DFC 480-R2 digital camera using the LAS imaging software (Leica, Germany).
For histological sections, stained embryos were re-fixed in 4% PFA, dehydrated, wax embedded, sectioned (8 µm) by a microtome (Leitz 1516) and stained with eosin. Images were taken with a Leica DM6000 B microscope equipped with a Leica 480 digital camera using the LAS software (Leica, Germany). (Nasevicius and Ekker, 2000) and injected at the 1-2 cell stage embryo. Rhodamine dextran (Molecular Probes) was usually co-injected as a tracer. After injection, embryos were raised in fish water (previously described) at 28ºC and observed up to the stage of interest. For a better observation, the injected embryos were anaesthetized using 0.016% tricaine (Ethyl 3-aminobenzoate methanesulfonate salt, Sigma Aldrich) in fish water. To assess the ideal concentration of morpholino we injected several dilutions and verified at 24 hpf the overall effects of the morpholino on embryo phenotype. The injection of tmem230a-MO1 at a concentration above or equal to 0.4 pmol/embryo led to morphological defects, such as head defects and bent tail (not shown), and increased mortality in a dose dependent manner ( Supplementary Fig. S4a ), suggesting the activation of unspecific mechanisms at those concentrations. While, at a concentration of 0.3 pmol/embryo and below the survival rate was high and the embryos had a normal morphology and development ( Supplementary Fig. S4a ). We proceded in a similar way to determine the concentration of splicing morpholino tmem230a-MO2 to inject and we found we could inject an higher dose (1pmol/embryo) of this morpholino with not apparent effects in the gross morphology of the embryo (Supplementary Fig S4b) .
Morpholino
Images were acquired using a Leica MZFLIII epifluorescence stereomicroscope equipped with a DFC 480-R2 digital camera and the LAS imaging software (Leica, Germany). 
Analysis of ISV cell number.
We scored ISV cell number by counting cell nuclei expressing the GFP in tg(fli1:nEGFP) y7 embryos at 29 hpf. We considered for our analysis the first 10 intersegmental vessels anterior to the anus. We mounted injected embryos of each sample in 1% low-melting agarose (adding some drops of tricaine as anaesthetic) and observed in was diluted to a concentration of 200 µM in E3 embryo medium as described (Westerfield, 1993) . tmem230a mRNA and std-MO injected embryos were dechorionated by pronase (Sigma Aldrich) treatment (Westerfield, 1993) and treated with DAPT from 17 hpf to 29 hpf at 28°C. As DAPT is prepared with DMSO, tmem230a mRNA and std-MO injected embryos were treated with E3 embryo medium containing the same concentration of DMSO used for the DAPT treated embryos.
Live-imaging analysis of Notch reporter expression.
To assay the capacity of Tmem230a to regulate Notch signalling, we injected tmem230a-
MO1 into 1-cell stage embryos generated from crossing the transgenic line
Tg(T2KTp1bglob:hmgb1-mCherry) with Tg(fli1a:EGFP) y1 . The level of mCherry fluorescence expression in the vessels of the embryos was scored by confocal microscopic analysis. We mounted five embryos at 48 hpf from each sample in 1.2%
low-melting agarose (adding some drops of tricaine as anaesthetic) and observed in every embryo the same group of 3 ISVs up to the yolk extension. Images were taken with a Leica TCS SP2 confocal microscope, using a water-immersion objective 40X.
Statistical analysis.
Statistical analysis was performed with one-way ANOVA analysis of variance technique and with Dunnett's post test using GraphPad PRISM versions 5.0 and 6.0 (GraphPad, San Diego, CA, USA). In the graphs, * and ** mark statistically significant data with a p value <0.05 and <0.01, respectively. Statistically highly significant data, with a p value <0.001, are marked by ***.
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Results
Tmem230 identification and bioinformatic analysis
We have Temporal expression of both zebrafish tmem230 genes (a and b) was analyzed in embryonic and early larval development and in adult organs and tissues by RT-PCR analysis ( Fig. 2a and Supplementary Fig. S2a ). Both transcripts were detected at all analyzed stages from cleavage up to 5 dpf, as well as in oocytes, suggesting that both transcripts are both maternally and zygotically expressed. Furthermore, tmem230a and tmem230b expression was detected in all adult organs and tissues tested (brain, eyes, gills, gut, heart, liver and muscle). Whole-mount in situ hybridization (WISH) analysis revealed that from the mid somitogenesis stage (15 somites) to 2 dpf, tmem230a has higher expression in the developing vascular system than tmem230b ( and Caudal Vein (CV) (Fig. 2c, c', d, h, i) . At 2 dpf, a strong hybridization signal was detected at the level of the mandibular arches and in the fin buds, and moreover tmem230a was expressed at low levels in the CV plexus region (Fig. 2e, f, g, j) . In contrast, no hybridization signal was detected for tmem230b in the forming vasculature Fig. S2d, d ',e). At 2 dpf, tmem230b was only slightly expressed in the mesencephalon (Supplementary Fig. S2f ).
Since our data indicate a robust tmem230a expression in the developing vasculature not overlapping with the expression of tmem230b, we investigated the role of Tmem230a in vascular development.
Tmem230a modulates ISV endothelial cell number.
To determine the role of tmem230a, we first looked to the effects of tmem230a knockdown, to reduce Tmem230a protein in the developing vasculature. To not interfere with the early embryonic expression of tmem230a, a gene knockdown approach with morpholinos was used. Knockdown experiments were performed by independent injections of two different morpholinos: a low dose tmem230a-MO1 and tmem230a-MO2, designed to block mRNA translation or splicing, respectively (Fig. 3) . The sequences of both tmem230a-morpholinos were analyzed to exclude cross targeting to tmem230b ( Supplementary Fig. S3a ). We injected tmem230a-MO1 at the selected dose of 0.3 pmol/embryo and tmem230a-MO2 at 1pmol/embryo in one cell stage tg(fli1:nEGFP) y7 embryos. These concentrations of morpholinos did not affect the gross phenotype of the zebrafish embryos and the main axial vessels appeared normal in all injected embryos at 29 hpf and 2 dpf ( (Fig. 3 a-g ). We counted cells in the first 10 intersegmental vessels anterior to the anus and found a statistically significant increase 3e,k) (Roman et al., 2002) . To further confirm these results, when we injected the spliceblocking tmem230a-MO2 at 1 pmol/embryo in the same transgenic line embryos, we observed a comparable increase in ISV cell number though with a different penetrance (Supplementary Fig. S4b and Fig. 3e,i,l) . The injection of tmem230a-MO2 which targets the exon2-intron2 boundary, generated a transcript unable to splice exon 2 from intron 2 ( Supplementary Fig. S3b ). Sequencing of the smaller PCR product confirmed a sequence skipping tmem230a exon 2 consistent with a previous report showing that targeting of a E2/I2 junction may result in exon 2 skipping (Morcos, 2007) . This mRNA having no starting codon in frame with the tmem230a sequence yields a non-functional tmem230a mRNA.
In parallel to the loss-of-function experiments, mRNA over-expression experiments were performed. We injected tmem230a mRNA (400 pg/embryo) in one cell stage tg(fli1:nEGFP) y7 embryos. As for the knock-down experiments, we counted the number of ISV cells present in the first 10 intersegmental vessels anterior to the anus. Consistent with the phenotype observed with the loss-of-function of Tmem230a, the gain-offunction experiment resulted into the opposite phenotype. We found a statistically significant (p<0.0001) decrease of the mean number of cells in ISVs in the tmem230a-over-expressing embryos (29.17 mean ISV cells present in the first 10 intersegmental vessels anterior to the anus for the tmem230a over-expressing embryos, n = 60, versus
35.06 mean cell number for the control, n = 32), (Fig. 3 j,k) . mRNA over-expression (400 pg/embryo) (Fig. 3l) .
Taken together these data suggest a bona fide role of tmem230a in regulating ISV cell number during angiogenesis. Considering that both morpholinos produced the same phenotypes, we performed all following experiments by injecting tmem230a-MO1 into embryos, which we indicate as tmem230a morphants.
Tmem230a knockdown affects angiogenic blood vessel growth rather than arterovenous endothelial cell fate.
The effect of Tmem230a in ISV cell number could be explained in two possible ways:
either Tmem230a affects blood vessel growth or regulates artero-venous cell fate switch.
To gain insight into the molecular events following tmem230a-MO1 injection, we analyzed the expression of different vascular markers: ephrin-B2 (efnb2a) and its receptor ephB4, specifically expressed in arterial and venous endothelium, and flk1 (vegf receptor 2, vegfr2), flt4 (vegf receptor 3, vegfr3) and dll4 (notch ligand delta-like 4) which are preferentially expressed in tip rather than in stalk cells (Adams and Alitalo, 2007; Blanco and Gerhardt, 2013; Fouquet et al., 1997; Gerety et al., 1999; Lawson et al., 2001; Phng and Gerhardt, 2009; Shutter et al., 2000; Siekmann and Lawson, 2007;  Thompson et al., 1998; Wang, 1998) . In std-MO and tmem230a-MO1 injected embryos, efnb2a and ephb4 expression levels were comparable (for efnb2a n=74, n=75
respectively and for ephb4 n=77, n=76, respectively; Fig. 4a-d) . In contrast, increase of flk1, flt4, and dll4 staining in ISVs and in the Dorsal Longitudinal Anastomotic Vessels (DLAVs) was observed in tmem230a morphants (for flk1 83% n=57; for flt4 79% n=52;
and for dll4 53% n=44, respectively) compared with control embryos (for flk1 n=16; for flt4 n=19; and for dll4 n=18; Fig. 4e-j) .
No change in efnb2a and ephB4, but increase in flk1, flt4, and dll4 marker levels in tmem230a morphants strongly suggests that more ISV cells were generated by tmem230a-MO1 injection. These results provided support that the role of tmem230a is restricted to angiogenic blood vessel growth and that tmem230a promotes angiogenic cell behavior rather than the determination of artero-venous cell fates. The increase of cell number can be due to various cellular processes including increase in cell proliferation and/or a result of cellular migration of ISV cells from the aorta. Previous studies have demonstrated that Notch restricts angiogenesis and that loss of the Notch ligand dll4 led to supernumerary endothelial cells within the ISA (Leslie et al., 2007; Siekmann and Lawson, 2007) . As tmem230a mRNA over-expression reduced ISV cell number, we wanted to determine whether tmem230a is involved in the Notch signaling pathway, and whether it acts synergistically with dll4 in regulating the ISV cell number. Two independent approaches were used to answer these questions. First, we co- injected into embryos subcritical doses of tmem230a-(0.07 pmol/embryo) and dll4-(0.09 pmol/embryo) MOs (Fig. 5a-f) . Results show that the subcritical doses of each morpholino do not cause alterations in ISV cell number when injected separately (Fig.   5e ). However, when subcritical doses of both dll4-and tmem230a-MOs were co-injected into the same embryos a statistically significant increase in ISV cell number was observed, suggesting a synergistic effect of Dll4 and Tmem230a (Fig. 5c,e) . Consistent with a role of Tmem230a in regulating ISV cell number, co-injection of tmem230a mRNA (400 pg/embryo) together with dll4-MO (0.4 pmol/embryo) rescued normal endothelial cell numbers in ISVs (Fig. 5d, 
f). As Dll4 is part of the Notch pathway and
Notch restricts angiogenesis we hypothesized that a second and independent way to block Notch signaling would also produce the same results. Therefore, we investigated the effect of tmem230a in a context where the Notch signaling was blocked by using the γ-secretase inhibitor, DAPT (Geling et al., 2002) . Consistent with the results obtained with the dll4-morphants, embryos treated with 200 µM DAPT showed an increase in the number of ISV cells compared to DMSO-control treated embryos (Fig. 5g ). Embryos injected with tmem230a mRNA and treated with DAPT showed a number of ISV cells comparable to that of std-MO injected control embryos treated with DMSO, while DMSO-control embryos injected with tmem230a mRNA showed a decrease in ISV cell number as previously seen (Fig. 3j,k) . These results confirm that embryos overexpressing tmem230a can rescue back the correct number of ISV cells in Notch signaling blocked embryos (Fig. 5g) . Taken together, these data are consistent with the hypothesis that Tmem230a acts synergistically with Dll4 and has a role mediating Notch signaling pathway for ISV development. All results presented here support that Tmem230a has a modulatory role in the Dll4/Notch signaling pathway to limit angiogenic cell behavior.
Discussion
In zebrafish, embryonic trunk angiogenesis takes place in two distinct waves: formation of primary and secondary sprouts. From about 20 hpf, primary sprouts bilaterally form from the DA to give rise to intersegmental arterial (ISA) vessels, which are completed by Here, we identified two tmem230 paralogous genes in zebrafish. In this work, we investigated the expression pattern and the function of Tmem230a.
As our preliminary data (Fig. 2) indicated that tmem230a may have diverse functions since it was expressed throughout embryonic development including pre-gastrulation development, to focus only on the role of tmem230a in vascular development we decided to modulate tmem230a levels by morpholinos. In contrast to morpholinos, transgenic technologies and use of the CRISPR-Cas9 approach to induce mutations could produce early phenotypes, thus, mask later developmental events, like the vascular phenotype that we were interested to study (Blum et al., 2015) . Injections of two independent tmem230a-MOs for the down regulation of Tmem230a led to the increase of endothelial cell number within the ISVs. Interestingly, over-expression of tmem230a mRNA resulted into the opposite phenotype, a marked decrease of endothelial cell number within the ISVs, supporting that the role of Tmem230a is to limit endothelial cell number and therefore modulate angiogenic vessel growth. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Our study is the first to identify TMEM230 as a novel regulator and modulator of angiogenesis associated blood vessel-network formation and growth. Recently, TMEM230 has been identified when mutated to have a role in Parkinson's disease. As to how TMEM230 mutation(s) contributes at the molecular level to the Parkinson's phenotype is still under investigation. (Baumann et al., 2017; Deng et al., 2016; Giri et al., 2017; He et al., 2016; Kim et al., 2017; Olszewska et al., 2016; Quadri et al., 2017; Wu et al., 2016; Yan et al., 2017) . Our study is the first to associate and characterize TMEM230
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to specific signaling pathways and provides first insight into how TMEM230 functions at the molecular level. Additionally, our study and the recent discovery of role of TMEM230 in Parkinson's disease suggest that novel genes with tantalizingly multiple functions in normal and disease vertebrate development are still to be discovered. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   23   23 and metastasis, TMEM230 protein may also be a target for cancer therapy by repressing new blood vessel growth.
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